Metraipolis › archive › dc_14cafd9bdcd9

Evaluation of Polmacoxib 2 mg for the Management of Hip and Knee Osteoarthritis: A Prospective, Single-Arm, Multicenter, Open-Label Study — Europe PMC PMID:41257112

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41257112
DOI
10.7759/cureus.94838
License (as archived)
solo-consultazione
Archived
2026-11-09T05:24:18.879Z
SHA-256 of the archived text
4569014ecc34acc6fb06d7aa910ea6283c31fe42d57dcad5529fd8419ccd674d
Stable URL of this page
https://metraipolis.com/documento/dc_14cafd9bdcd9

How to cite

Evaluation of Polmacoxib 2 mg for the Management of Hip and Knee Osteoarthritis: A Prospective, Single-Arm, Multicenter, Open-Label Study — Europe PMC PMID:41257112 — Europe PMC (en), https://europepmc.org/article/MED/41257112 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_14cafd9bdcd9 (Metraipolis archive dc_14cafd9bdcd9, sha256 4569014ecc34acc6fb06d7aa910ea6283c31fe42d57dcad5529fd8419ccd674d)
BibTeX
@misc{dc14cafd9bdcd9,
  title = {Evaluation of Polmacoxib 2 mg for the Management of Hip and Knee Osteoarthritis: A Prospective, Single-Arm, Multicenter, Open-Label Study — Europe PMC PMID:41257112},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41257112},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_14cafd9bdcd9; sha256 4569014ecc34acc6fb06d7aa910ea6283c31fe42d57dcad5529fd8419ccd674d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41257112. Agents can read the archived copy with the MCP tool read_document.